Drugnews|藥時事

Applied BioCode

Applied BioCode Corporation

6598 · TWSE-listed

Applied BioCode focuses on molecular diagnostic platforms and pathogen testing, as of 2026-11-01.

Pipeline and products

No publicly disclosed new-drug pipeline.

Key events

Related Drugnews articles

No related articles in this language.